Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kremezin in chronic kidney disease (CAP-KD)
NCT00456859Phase 4Completed
- Sponsor
- HOPE Research Institute
- Start
- Apr 2004
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of activated charcoal in chronic kidney disease (CKD), sponsored by HOPE Research Institute. Started Apr 2004; status: completed.
02
Drugs
activated charcoal
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00456859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00456859.